Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy N Rich

Showing results (11-20 of 322) with videos related to

Pageof 33
Sort By:
Drugs of Today (Barcelona, Spain : 1998)|December 1, 2006
Vandetanib, a novel multitargeted kinase inhibitor, in cancer therapySith Sathornsumetee, Jeremy N Rich
Expert Review of Anticancer Therapy|July 13, 2006
New treatment strategies for malignant gliomasSith Sathornsumetee, Jeremy N Rich
Cell Research|May 20, 2020
Reprogramming the microenvironment: tricks of tumor-derived astrocytesGuoxin Zhang, Jeremy N Rich
Current Topics in Microbiology and Immunology|June 29, 2010
Hypoxia and hypoxia inducible factors in cancer stem cell maintenanceZhizhong Li, Jeremy N Rich
Current Pharmaceutical Design|January 29, 2008
Antiangiogenic therapy in malignant glioma: promise and challengeSith Sathornsumetee, Jeremy N Rich
Cell Stem Cell|March 29, 2008
Chemotherapy and cancer stem cellsJeremy N Rich, Shideng Bao
Nature Cell Biology|May 4, 2012
Holding on to stemnessJustin D Lathia, Jeremy N Rich
Cancer Cell|April 1, 2022
Patient-derived explants as tumor modelsChristopher G Hubert, Jeremy N Rich
Nature Reviews. Cancer|September 21, 2007
Making a tumour's bed: glioblastoma stem cells and the vascular nicheRichard J Gilbertson, Jeremy N Rich
Molecules and Cells|August 6, 2009
Biology of glioma cancer stem cellsDeric M Park, Jeremy N Rich
Pageof 33

Showing results (11-20 of 322) with videos related to

Sort By:
Pageof 33
Drugs of Today (Barcelona, Spain : 1998)|December 1, 2006
Vandetanib, a novel multitargeted kinase inhibitor, in cancer therapySith Sathornsumetee, Jeremy N Rich
Expert Review of Anticancer Therapy|July 13, 2006
New treatment strategies for malignant gliomasSith Sathornsumetee, Jeremy N Rich
Cell Research|May 20, 2020
Reprogramming the microenvironment: tricks of tumor-derived astrocytesGuoxin Zhang, Jeremy N Rich
Current Topics in Microbiology and Immunology|June 29, 2010
Hypoxia and hypoxia inducible factors in cancer stem cell maintenanceZhizhong Li, Jeremy N Rich
Current Pharmaceutical Design|January 29, 2008
Antiangiogenic therapy in malignant glioma: promise and challengeSith Sathornsumetee, Jeremy N Rich
Cell Stem Cell|March 29, 2008
Chemotherapy and cancer stem cellsJeremy N Rich, Shideng Bao
Nature Cell Biology|May 4, 2012
Holding on to stemnessJustin D Lathia, Jeremy N Rich
Cancer Cell|April 1, 2022
Patient-derived explants as tumor modelsChristopher G Hubert, Jeremy N Rich
Nature Reviews. Cancer|September 21, 2007
Making a tumour's bed: glioblastoma stem cells and the vascular nicheRichard J Gilbertson, Jeremy N Rich
Molecules and Cells|August 6, 2009
Biology of glioma cancer stem cellsDeric M Park, Jeremy N Rich
Pageof 33